GLENLEA MEDICAL AND AESTHETICS LTD
- 96040Physical well-being activities
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-08-31 | 2024-08-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (5 events)Click to expand
- 2025-09-18📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-04-04📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-08-11🏢Company incorporatedAs GLENLEA MEDICAL AND AESTHETICS LTD
- 2023-08-11➕PEACOCK, Lynne Jean appointeddirector
- 2023-08-11📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.7 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Lynne Jean Peacock Individual · British · DOB 01/1983 · age 43 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 11/08/2023 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · KA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| GRACELAND NURSING HOME LIMITED→ SC196946 · est 1999 · no financials extracted | — | — | — | — | 26y | — | — |
| GREYSPACE THERAPY LIMITED→ SC844995 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| GSC SHAWLANDS LTD→ SC864449 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| HAMISH SIMPSON LTD→ SC691507 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| HANSEL FOUNDATION→ SC038440 · est 1963 · no financials extracted | — | — | — | — | 63y | — | — |
| HEATHER LODGE CIC→ SC747935 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| INAMO LIMITED→ SC076251 · est 1981 · no financials extracted | — | — | — | — | 44y | — | — |
| INTERNATIONAL HOLDINGS MANAGEMENT LIMITED→ SC408720 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| JAMES G. BRODLIE LIMITED→ SC078353 · est 1982 · no financials extracted | — | — | — | — | 44y | — | — |
| JAMIESON & ADAMS LTD→ SC753767 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| JAN DE VRIES HEALTHCARE (BLYTHSWOOD) LTD→ SC519589 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| JANUS MEDICAL LIMITED→ SC736700 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.